Infectious keratitis after corneal crosslinking for keratoconus caused by levofloxacin-resistant microorganisms
Tóm tắt
We present seven cases of infectious keratitis after corneal crosslinking (CXL) to attenuate keratoconus progression. Of 524 consecutive patients who underwent CXL, 7 cases (4 males and 3 females; 21.5 ± 7.1 years) developed postoperative infectious keratitis were retrospectively reviewed. CXL was performed using the Dresden protocol or an accelerated protocol involving epithelial removal. All cases appeared normal on the day after surgery, but subsequently developed eye pain, blurred vision, corneal infiltration, inflammation of the anterior chamber, and ciliary injection on day 2 or 3. Methicillin-resistant Staphylococcus aureus was cultured from two eyes, methicillin-sensitive Staphylococcus aureus from two eyes, and Streptococcus pneumoniae from one eye. All detected bacteria were resistant to levofloxacin (LVFX). Five of the seven cases, especially four of the five severe cases with hypopyon, had a history of atopic dermatitis. All cases were observed after 2015. Infectious keratitis after CXL caused by microbes resistant to LVFX is increasing. In addition to careful postoperative observation of the cornea, preoperative evaluation of bacteria within the conjunctival sac evident on nasal swab cultures may be useful to identify potentially problematic microbes and inform the selection of appropriate antibiotics.
Tài liệu tham khảo
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135: 620–627.
Raiskup-Wolf F, Hoyer A, Spoerl E, et al. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg. 2008; 34: 796–801.
Wittig-Silva C, Whiting M, Lamoureux E, et al. Randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg. 2008; 24: S720-725.
Hersh PS, Stulting RD, Muller D, et al. United States Crosslinking Study Group. United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment. Ophthalmology. 2017; 124: 1259–1270.
Kobashi H, Rong SS. Corneal Collagen Cross-Linking for Keratoconus: Systematic Review. Biomed Res Int. 2017;2017:8145651.
Mohamed-Noriega K, Butrón-Valdez K, Vazquez-Galvan J, et al. Corneal melting after collagen cross-linking for keratoconus in a thin cornea of a diabetic patient treated with topical nepafenac: A case report with a literature review. Case Rep Ophthalmol. 2016; 7: 119–124.
Seiler TG, Schmidinger G, Fischinger I, et al. Complications of corneal cross-linking. Complications of corneal cross-linking. Ophthalmologe. 2013; 110: 639–644.
Sasaki T, Ide T, Toda I, et al. Amniotic Membrane Transplantation as a Treatment for sterile infiltration and corneal melting after corneal crosslinking for keratoconus. Case Rep Ophthalmol. 2018; 9: 185–189.
Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 2009; 35: 1358–1362.
Mereaux D, Knoeri J, Jouve L, et al. Sterile keratitis following standard corneal collagen crosslinking: A case series and literature review. J Fr Ophtalmol. 2019; 42: 603–611.
Shetty R, Kaweri L, Nuijts RM, et al. Profile of microbial keratitis after corneal collagen cross-linking. Biomed Res Int. 2014;2014:340509.
Kodavoor SK, Sarwate NJ, Ramamurhy D. Microbial keratitis following accelerated corneal collagen cross-linking. Oman J Ophthalmol. 2015; 8: 111–3.
Fasciani R, Agresta A, Caristia A, et al. Methicillin-Resistant Staphylococcus aureus Ocular Infection after Corneal Cross-Linking for Keratoconus: Potential Association with Atopic Dermatitis. Case Rep Ophthalmol Med. 2015;2015:613273.
Oakey Z, Thai K, Garg S. Bilateral corneal perforation due to MRSA keratitis in a crosslinking patient. GMS Ophthalmol Cases. 2017;7: Doc21.
Kodavoor SK, Tiwari NN, Ramamurthy D. Profile of infectious and sterile keratitis after accelerated corneal collagen cross-linking for keratoconus. Oman J Ophthalmol. 2020; 13: 18–23.
Schear M, Ragam A, Seedor J, et al. Rapid keratitis and perforation after corneal collagen cross-linking. Am J Ophthalmol Case Rep. 2020; 18: 100658.
Al-Amry M, Mudhaiyan T, Al-Huthail R, et al. Infectious crystalline keratopathy after corneal cross-linking. Middle East Afr J Ophthalmol. 2017; 24: 100–102.
Zamora KV, Males JJ. Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea. 2009; 28: 474–476.
Pollhammer M, Cursiefen C. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg. 2009; 35: 588–589.
Sharma N, Maharana P, Singh G, et al. Pseudomonas keratitis after collagen crosslinking for keratoconus: case report and review of literature. J Cataract Refract Surg. 2010; 36: 517–520.
Pérez-Santonja JJ, Artola A, Javaloy J, et al. Microbial keratitis after corneal collagen crosslinking. J Cataract Refract Surg. 2009; 35: 1138–1140.
Kato N, Konomi K, Saiki M, et al. Deep stromal opacity after corneal cross-linking. Cornea. 2013; 32: 895–898.
Kato N, Negishi K, Sakai C, et al. Five-year Outcomes of Corneal Cross-Linking for Keratoconus: Comparison Between Conventional and Accelerated Procedures. Cornea. 2020; 39: e1.
Noor IH, Seiler TG, Noor K, et al. Continued Long-term Flattening After Corneal Cross-linking for Keratoconus. J Refract Surg. 2018; 34: 567–570.
Sitaula S, Singh SK, Gurung A. Bilateral viral keratitis following corneal collagen crosslinking for progressive keratoconus. J Ophthalmic Inflamm Infect. 2019; 9: 16.
Maharana PK, Sahay P, Sujeeth M, et al. Microbial Keratitis After Accelerated Corneal Collagen Cross-Linking in Keratoconus. Cornea. 2018; 37: 162–167.
Asbell PA, DeCory HH. Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study. PLoS One. 2018; 13: e0205814.
Asbell PA, Sanfilippo CM, Sahm DF, et al. Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 2018. JAMA Ophthalmol. 2020; 138: 1–12.
Deguchi H, Kitazawa K, Kayukawa K, et al. The trend of resistance to antibiotics for ocular infection of Staphylococcus aureus, coagulase-negative staphylococci, and Corynebacterium compared with 10-years previous: A retrospective observational study. PLoS One. 2018; 13: e0203705.
Kamo J, Soshiu M, Muramatsu S, et al. Change in conjunctivitis bacteria susceptibilities to antibiotics between 2008 and 2011. J Eye 2014; 31: 1037–1042.
Kamo J, Muramatsu S, Akazawa H, et al. Recommendation of antibiotics for the eyes by age group in 2018 based on microorganism sensitivity. J Eye 2020; 37: 484–489.
Fukuda M, Ohashi H, Matsumoto C, et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea. 2002; 21: S86-89.
Kitazawa K, Sotozono C, Sakamoto M, et al. Nasal and conjunctival screening prior to refractive surgery: an observational and cross-sectional study. BMJ Open. 2016; 6: e010733